We are live on ! Find out more
NNVC icon

NanoViricides

57 hedge funds and large institutions have $20.4M invested in NanoViricides in 2014 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

451% more call options, than puts

Call options by funds: $1.32M | Put options by funds: $239K

243% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 7

129% more capital invested

Capital invested by funds: $8.92M → $20.4M (+$11.5M)

43% more funds holding

Funds holding: 4057 (+17)

25% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 8

Holders
57
Holders Change
+17
Holders Change %
+42.5%
% of All Funds
1.64%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
24
Increased
10
Reduced
8
Closed
7
Calls
$1.32M
Puts
$239K
Net Calls
+$1.08M
Net Calls Change
+$618K
Name Holding Trade Value Shares
Change
Change in
Stake
RG
26
Rathbones Group
United Kingdom
$119K
Manulife (Manufacturers Life Insurance)
27
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$119K +$99.5K +1,402 New
AIG
28
American International Group
New York
$116K +$93.6K +1,319 +2,162%
RhumbLine Advisers
29
RhumbLine Advisers
Massachusetts
$111K +$93.5K +1,317 New
Morgan Stanley
30
Morgan Stanley
New York
$106K -$15.3K -215 -15%
U
31
UBS
Switzerland
$96K -$429K -6,044 -84%
ProShare Advisors
32
ProShare Advisors
Maryland
$83K +$69.3K +977 New
RCM
33
RNC Capital Management
California
$73K
BA
34
BlackRock Advisors
Delaware
$72K +$60.1K +847 New
Millennium Management
35
Millennium Management
New York
$67K +$56.3K +793 New
Jacobs Levy Equity Management
36
Jacobs Levy Equity Management
New Jersey
$65K +$54.7K +770 New
SO
37
STRS Ohio
Ohio
$58K +$48.6K +685 New
D.E. Shaw & Co
38
D.E. Shaw & Co
New York
$44K +$37.1K +523 New
Wells Fargo
39
Wells Fargo
California
$35K -$26.2K -369 -47%
Group One Trading
40
Group One Trading
Illinois
$33K -$48.8K -687 -64%
NSIM
41
North Star Investment Management
Illinois
$25K
AllianceBernstein
42
AllianceBernstein
Tennessee
$24K +$19.9K +280 New
Bank of America
43
Bank of America
North Carolina
$17K -$26.6K -375 -65%
TRCT
44
Tower Research Capital (TRC)
New York
$15K +$5.96K +84 +80%
VFA
45
Virtus Fund Advisers
Connecticut
$14K +$12.1K +171 New
Bank of Montreal
46
Bank of Montreal
Ontario, Canada
$12K
Creative Planning
47
Creative Planning
Kansas
$10K
SSB
48
Sandy Spring Bank
Maryland
$10K +$3.34K +47 +66%
DADC
49
D.A. Davidson & Co
Montana
$7K
Royal Bank of Canada
50
Royal Bank of Canada
Ontario, Canada
$5K

NNVC Hedge Fund Activity: Q2 2014 in Review

57 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q2 2014, worth a combined $20.4M — up 129% from $8.92M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new NNVC positions and 7 closed out — a net gain of 17 holders — while 10 added to existing stakes and 8 trimmed.

The largest buyer was BlackRock Fund Advisors, opening a new position worth an estimated $3.5M. The largest seller was Susquehanna International Group, exiting entirely with an estimated $570K sold.

  • 57 institutional investors held NanoViricides (NNVC) as of Q2 2014, up from 40 in Q1 2014.
  • Funds reported $20.4M of NanoViricides stock for Q2 2014, up 129% quarter-over-quarter.
  • 24 funds opened new NanoViricides positions in Q2 2014 and 7 closed out, a net change of +17 holders.
  • The largest NanoViricides buyer in Q2 2014 was BlackRock Fund Advisors, an estimated $3.5M added.
  • The largest NanoViricides seller in Q2 2014 was Susquehanna International Group, an estimated $570K sold.

Based on aggregated 13F filings for Q2 2014.